TKNO
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when Alpha Teknova, Inc. publishes a filing, an earnings call transcript or a press release.
Get TKNO alertsMatt Lowell is recorded as CFO at Alpha Teknova, Inc. (TKNO). Matt Lowell has spoken on 9 earnings calls and 1 other investor event across 1 company, most recently for Alpha Teknova, Inc. on August 5, 2026. Alpha Teknova, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Alpha Teknova, Inc. includes Stephen Gunstream (CEO and Board Member), Matthew Lowell (CFO), Damon Terrill (General Counsel) and 4 others.
“As Stephen explained, total revenue was up 18% for the second quarter of 2026 compared to the same quarter prior year. This was also the highest quarterly revenue the company has achieved in its history.”
“As Stephen explained, revenue was up 13% for the first quarter of 2026 compared to the same quarter prior year. This was also the first Q1 in which we earned over $11 million in revenue in nearly three years.”
“Yes, we're very excited. we've been spending the last several years building some substantial capabilities. And because those things are largely built at this point, it gives us a significant opportunity to get towards profitability and then become profitability in the near future.”
“I'm pleased with our financial performance in 2025. As Stephen mentioned, we finished the year with momentum, delivering 8% and 7% year-over-year revenue growth in the fourth quarter and full year of 2025, respectively.”
“Overall, we delivered great financial results for the third quarter 2025. As Stephen noted, revenue was $10.5 million, a 9% increase from $9.6 million in the third quarter of 2024.”
TKNO
Drug Manufacturers - Specialty & Generic · Healthcare
CFO